Literature DB >> 29567902

A rare case of primary female urethral adenocarcinoma: Columnar type with colonic adenocarcinoma features.

Prithal Gangadhar1, Muktha R Pai1, I Sandhya1.   

Abstract

Female urethral carcinoma is extremely rare and accounts for 0.02% of all women's cancers and <1% of cancers in the female genitourinary tract. Adenocarcinoma accounts for only 10% of urethral carcinomas in females. Due to their location, presentation is usually late and tumors are often missed on physical examination. As in this case, nonspecific symptoms in the early stages may delay the diagnosis in most patients. Herein, we present an extremely rare case of the columnar type of primary female urethral adenocarcinoma exhibiting colonic adenocarcinoma features which to the authors' best knowledge has not been reported to date. The present study emphasizes the importance of a careful clinical examination and also highlights the role of imaging studies, and biopsy in making an accurate preoperative diagnosis of this rare disease. The disease may have devastating sequelae due to local and metastatic involvement if not recognized and treated earlier.

Entities:  

Keywords:  Columnar type; Female Urethral adenocarcinoma; Skene's gland

Mesh:

Year:  2018        PMID: 29567902     DOI: 10.4103/IJPM.IJPM_745_16

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  2 in total

1.  Brachytherapy for the Conservative Treatment of Female Peri-Urethral Carcinoma.

Authors:  Mickaël Andraud; Manon Kissel; Roger Sun; Elie Rassy; Sophie Espenel; Samir Achkar; Philippe Morice; Christine Haie-Meder; Sébastien Gouy; Cyrus Chargari
Journal:  Cancers (Basel)       Date:  2022-02-08       Impact factor: 6.639

2.  Adenosquamous Carcinoma of Skene's Gland: A Case Report and Literature Review.

Authors:  Qian Gao; Xiaoyun Liu; Lin Ye; Tingting Lv; Yanyi Teng; Jian Lan; Tingchao Li; Min Tian; Juqi Chen; Shanshan He; Shengyan Xie; Yan Zou
Journal:  Front Oncol       Date:  2022-08-09       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.